22-36921806-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_000395.3(CSF2RB):c.-172-230T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.443 in 151,746 control chromosomes in the GnomAD database, including 16,889 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.44 ( 16889 hom., cov: 32)
Consequence
CSF2RB
NM_000395.3 intron
NM_000395.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.03
Genes affected
CSF2RB (HGNC:2436): (colony stimulating factor 2 receptor subunit beta) The protein encoded by this gene is the common beta chain of the high affinity receptor for IL-3, IL-5 and CSF. Defects in this gene have been reported to be associated with protein alveolar proteinosis (PAP). [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 22-36921806-T-C is Benign according to our data. Variant chr22-36921806-T-C is described in ClinVar as [Benign]. Clinvar id is 1271192.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.582 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSF2RB | ENST00000403662.8 | c.-172-230T>C | intron_variant | Intron 1 of 13 | 5 | NM_000395.3 | ENSP00000384053.3 | |||
ENSG00000304449 | ENST00000803517.1 | n.232+3944A>G | intron_variant | Intron 1 of 1 | ||||||
ENSG00000304449 | ENST00000803518.1 | n.275-2867A>G | intron_variant | Intron 1 of 1 | ||||||
ENSG00000304449 | ENST00000803519.1 | n.261+1493A>G | intron_variant | Intron 1 of 1 |
Frequencies
GnomAD3 genomes AF: 0.443 AC: 67182AN: 151630Hom.: 16881 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
67182
AN:
151630
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.443 AC: 67215AN: 151746Hom.: 16889 Cov.: 32 AF XY: 0.450 AC XY: 33363AN XY: 74164 show subpopulations
GnomAD4 genome
AF:
AC:
67215
AN:
151746
Hom.:
Cov.:
32
AF XY:
AC XY:
33363
AN XY:
74164
show subpopulations
African (AFR)
AF:
AC:
8172
AN:
41188
American (AMR)
AF:
AC:
9025
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
1787
AN:
3468
East Asian (EAS)
AF:
AC:
3091
AN:
5158
South Asian (SAS)
AF:
AC:
1918
AN:
4824
European-Finnish (FIN)
AF:
AC:
5962
AN:
10582
Middle Eastern (MID)
AF:
AC:
141
AN:
294
European-Non Finnish (NFE)
AF:
AC:
35684
AN:
67924
Other (OTH)
AF:
AC:
952
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1791
3582
5372
7163
8954
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.